Invesco Gold & Special Minerals Fund A USD Acc vs UBS Lux Equity Fund Biotech USD

Invesco Gold & Special Minerals Fund A USD Acc vs UBS Lux Equity Fund Biotech USD

1. Invesco Gold & Special Minerals Fund A USD Acc

  • Security

    Invesco Gold & Special Minerals Fund A USD Acc

  • Fee

    2.00%

  • ISIN

    LU0505655562

  • Holdings

    10

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 14 holdings in Invesco Gold & Special Minerals Fund A USD Acc, where the largest holding is Northern Star Resources (4.86), followed by Agnico Eagle Mines (3.6) and Newmont (3.55). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in Invesco Gold & Special Minerals Fund A USD Acc and UBS Lux Equity Fund Biotech USD.

Invesco Gold & Special Minerals Fund A USD Acc UBS Lux Equity Fund Biotech USD
1. Northern Star Resources Ltd
Australia
4.86 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Agnico Eagle Mines Ltd
Canada
3.6 %
2. Moderna Inc
9.21 %
3. Newmont Corp
USA
3.55 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. OceanaGold Corp
Australia
3.53 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Artemis Gold Inc
Canada
3.32 %
5. AbbVie Inc
USA
4.91 %
6. K92 Mining Inc
Canada
3.32 %
6. Gilead Sciences Inc
USA
4.66 %
7. Barrick Mining Corp
USA
3.28 %
7. Amgen Inc
USA
4.43 %
8. Anglogold Ashanti Ltd
South Africa
2.98 %
8. BioNTech SE
4.13 %
9. Kinross Gold Corp
Canada
2.9 %
9. Karuna Therapeutics Inc
3.75 %
10. Gold Fields ADR
South Africa
2.9 %
-

The list of fund holdings was last updated on July 25, 2025.